Skip to main content
Key Specialties
Cardiology Diabetology Endocrinology Gastroenterology Geriatrics and Gerontology Gynecology and Obstetrics Hematology Infectious Disease Internal Medicine Nephrology Neurology Oncology Pediatrics Respiratory Medicine Rheumatology Surgery
Congress Coverage
2024 ACC Congress 2023 ESMO Congress 2023 EASD Congress 2023 ERS Congress 2023 ESC Congress
Clinical Collections
Advances in Alzheimer’s

Keynote webinar | Spotlight on medication adherence

LIVE: Thursday 27th June 2024, 18:00-19:30 (CEST)
Join our expert panel to discover why you need to understand the drivers of non-adherence in your patients, and how you can optimize medication adherence in your clinics to drastically improve patient outcomes.
ADVANCED SEARCH
Log in
Top
Inflammation Research
Metadata
Title
Expression of histamine degrading enzymes in guinea pig tissues
Authors
S. Rajtar
J. Feurle
H. G. Schwelberger
T. Irman-Florjanc
Publication date
01-04-2006
Publisher
Birkhäuser-Verlag
Published in
Inflammation Research / Issue Special Issue 1/2006
Print ISSN: 1023-3830
Electronic ISSN: 1420-908X
DOI
https://doi.org/10.1007/s00011-005-0043-z

Other articles of this Special Issue 1/2006

Inflammation Research 1/2006 Go to the issue

Original Research Paper

Origins of plasma amine oxidases in different mammalian species

Original Research Paper

Effect of genistein on agonist-induced airway smooth muscle contraction

Original Research Paper

Histamine in selected beer samples

Original Research Paper

Histamine modulates cellular events involved in tumour invasiveness in pancreatic carcinoma cells

Original Research Paper

Fluorescent benzofuran histamine H3 receptor antagonists with sub-nanomolar potency

Original Research Paper

Histamine and oxygen radicals of blood in the course of cardiopulmonary bypass (CPB)
Live Webinar | 27-06-2024 | 18:00 (CEST)

Keynote webinar | Spotlight on medication adherence

Reserve your place

Live: Thursday 27th June 2024, 18:00-19:30 (CEST)

WHO estimates that half of all patients worldwide are non-adherent to their prescribed medication. The consequences of poor adherence can be catastrophic, on both the individual and population level.

Join our expert panel to discover why you need to understand the drivers of non-adherence in your patients, and how you can optimize medication adherence in your clinics to drastically improve patient outcomes.

Prof. Kevin Dolgin
Prof. Florian Limbourg
Prof. Anoop Chauhan
Developed by: Springer Medicine
Obesity Clinical Trial Summary

At a glance: The STEP trials

Read more

A round-up of the STEP phase 3 clinical trials evaluating semaglutide for weight loss in people with overweight or obesity.

Developed by: Springer Medicine
Image Credits